Palasan, Charles A.

HRN: 21-59-43  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/16/2022
AMPICILLIN 1GM (VIAL)
07/16/2022
07/23/2022
IVTT
550mg
Q12
Pcap
Waiting Final Action 
07/20/2022
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
07/20/2022
07/27/2022
IV
180mg
Q24
Aspiration Pneumonia
Waiting Final Action 
07/20/2022
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
07/20/2022
07/27/2022
IV
1,200mg
Q6
Aspiration Pneumonia
Waiting Final Action 
07/25/2022
CO-AMOXICLAV 457MG/5ML, 70ML SUSPENSION (BOT)
07/25/2022
08/01/2022
PO
3ml
Bid
Pcap C
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: